+++
date = "2025-10-09T17:27:46+02:00"
draft = false
title = "Niacin: The Master Key of Renewal"
description = "From pellagra to psychiatry and longevity, this chapter explores how niacin (vitamin B3) restores balance across energy, mind, and metabolism."
tags = ["health", "niacin", "vitamin-b3", "NAD+", "orthomolecular", "longevity", "detox", "psychiatry"]
+++

---

### Prologue  

**Niacin** is one of the most versatile and misunderstood nutrients in modern medicine.  
First recognized for curing **pellagra**, it later revealed astonishing effects in **psychiatry**, **addiction recovery**, and **cardiovascular health**.  
As a direct precursor to **NAD+**, it fuels the body’s energy, repair, and longevity systems, while also acting as a **detoxifier** and **vascular regulator**.  
For decades, pioneers like **Abram Hoffer** and **Linus Pauling** championed its potential, even as mainstream medicine dismissed their findings.  
Today, as research on **NAD+** and **sirtuins** brings niacin back into focus, its legacy reminds us that sometimes _the simplest molecules_ hold the deepest power.  
This chapter explores niacin’s story — from deficiency disease to **metabolic corrector**.  

---

### Vitamin B3 at a Glance

**Vitamin B3** (collectively called **niacin**) is a family of related compounds your body uses to make **NAD+**, a central molecule for **energy**, **repair**, and **detoxification**.

**Key forms**  
- **Niacin (nicotinic acid):** classic form, causes the **“flush,”** improves cholesterol and circulation.  
- **Niacinamide (nicotinamide):** flush-free, anti-inflammatory, but doesn’t improve cholesterol.  
- **Other versions:** **sustained-release** and **“no-flush”** products carry safety issues or reduced benefits; newer compounds like **NR (nicotinamide riboside)** and **NMN (nicotinamide mononucleotide)** are downstream precursors.

**Deficiency (pellagra):** once epidemic, caused the **“four Ds” — dermatitis, diarrhea, dementia, and death** — and was cured by simple niacin repletion.

_Throughout this chapter, “niacin” usually refers to **nicotinic acid** unless otherwise specified._

### Origins: Searching for a Methyl Acceptor

In the early 1950s, psychiatrist **Abram Hoffer** was searching for a nutrient that could stabilize patients with **schizophrenia**. His hypothesis was that an abnormal metabolite, _adrenochrome (oxidized adrenaline)_, was disturbing brain chemistry and producing hallucinations.

While modern evidence has not confirmed adrenochrome as a definitive neurotoxin, Hoffer’s hypothesis framed a groundbreaking biochemical perspective on psychiatric illness that inspired decades of orthomolecular research.


As described in the **Vitamin C chapter**, this imbalance begins upstream in the stress response itself: cortisol and adrenaline rise, but the protective surge of vitamin C never follows. Without ascorbate, adrenaline oxidizes into **adrenochrome**, amplifying oxidative and neurochemical stress. **Niacin**, by replenishing **NAD⁺**, finishes the circuit — metabolizing adrenochrome and stabilizing the redox imbalance left unresolved by vitamin C deficiency. Together, **vitamin C and niacin** form the body’s natural **stress‑response pair**, restoring both chemical and electrical equilibrium.

While modern research has not confirmed adrenochrome as a primary cause of schizophrenia, Hoffer’s framework was pioneering in proposing that psychiatric illness could stem from redox and methylation imbalances rather than purely psychological causes.

**Niacin (vitamin B3)** emerged as a candidate because it functions as a **methyl acceptor**: by accepting methyl groups it competes for the same methyl donors (**SAMe**) required by phenylethanolamine N-methyltransferase (**PNMT**) to convert noradrenaline to adrenaline, thereby reducing adrenaline formation and the downstream production of adrenochrome. At the same time, **vitamin C** reduced the oxidation of adrenaline, preventing adrenochrome from forming in the first place. Together, they created a two-pronged approach: **vitamin C** reduced the oxidation of adrenaline, while **niacin** limited adrenaline’s formation at the source — both acting to prevent adrenochrome buildup.

Hoffer’s clinical reports documented thousands of patients who improved when given high-dose **niacin** and **vitamin C**. **Hallucinations diminished, mood stabilized, and hospitalizations decreased.**

_“Schizophrenia is not a psychodynamic mystery. It is a biochemical imbalance that can be corrected.” — **Abram Hoffer**_

Though his work was dismissed by mainstream psychiatry, Hoffer laid the foundation for what he called **orthomolecular psychiatry**: restoring mental health by providing the body with the molecules it needs in the right amounts.

Before Hoffer’s discoveries, **niacin** was already known for its dramatic ability to cure **pellagra**, a devastating deficiency disease that swept through the American South in the early 20th century. 
Pellagra was marked by the **“four Ds” — dermatitis, diarrhea, dementia, and death**. 
Entire communities suffered, and for decades its cause was debated until Joseph Goldberger, a physician with the U.S. Public Health Service, demonstrated that it was rooted in poor diet, not infection. Simply adding niacin-rich foods or supplementation reversed the condition. 

Just as pellagra showed that **niacin deficiency** could destroy both body and mind, Hoffer began to suspect that modern psychiatric illness could reflect a subtler **insufficiency of niacin relative to demand**.

This history underscored how profoundly **vitamin B3** shapes not only physical health but also **mental stability** — a clue that set the stage for Hoffer’s later psychiatric investigations.

In some ways, Hoffer’s work could be seen as treating a modern biochemical ‘pellagra of the brain’ — not deficiency in the strict sense, but **insufficiency of niacin relative to metabolic demand**.

### Bill W. and Alcoholics Anonymous

One of Hoffer’s most influential allies was **Bill Wilson (Bill W.)**, co-founder of **Alcoholics Anonymous**. Introduced to **niacin** by Hoffer, Bill began experimenting with it himself. Within days, he reported that the **depression and anxiety** that had plagued him for years began to lift.

He shared **niacin** with friends in AA, and many described similar improvements in mood and reduction in cravings. Although the leadership of AA never formally endorsed niacin, Bill’s quiet advocacy meant that thousands of recovering alcoholics came into contact with it.

_“It gave me a new lease on life. Within days I felt the depression and anxiety lift.” — **Bill W.**_

### Biochemistry: Niacin and the NAD+ Web

**Niacin** is more than a simple vitamin. It is a **precursor to NAD+ (nicotinamide adenine dinucleotide)**, one of the most central molecules in biology. **NAD+** participates in more than 400 enzymatic reactions, acting as the main electron carrier in the electron transport chain, where mitochondria generate **ATP**. It is also consumed by enzymes that repair **DNA**, regulate **inflammation**, and activate **sirtuins** — the so-called longevity regulators.

During times of **infection, inflammation, or psychological stress**, **NAD+** becomes depleted, leaving cells weakened. Restoring it is not just about energy production, but also about **resilience, repair, and stable brain function**.

There are multiple pathways to **NAD+**. **Niacin (nicotinic acid)** feeds into the **Preiss–Handler pathway**. **Niacinamide (nicotinamide)** is recycled through the **salvage pathway**. **Tryptophan** can be converted into NAD+ through the **kynurenine pathway**, but this is inefficient, requiring about 60 mg of tryptophan to make 1 mg of niacin equivalent. More recently, compounds like **NMN** and **NR** have been promoted, but they enter the salvage pathway further downstream.
  
Because **niacin** sits further upstream, its conversion to **NAD+** is naturally **rate-limited**. This means the body maintains control, preventing runaway effects. By contrast, **NMN** and **NR** feed in further downstream, bypassing some feedback control points. While this can make NAD+ restoration more rapid, it also raises open questions about long-term metabolic regulation — one reason niacin remains the most physiologically balanced and time-tested option.

This laid the groundwork for modern longevity researchers like **David Sinclair**, who helped bring **NAD+** into mainstream science.

_“Orthomolecular medicine is the treatment of disease by the provision of the optimum molecular environment, especially for the brain.” — **Linus Pauling**_

### Sinclair and the Longevity Connection

Decades after Hoffer’s psychiatric work, **David Sinclair** and others made **NAD+** famous in the context of **aging**. They showed how NAD+ declines with age, contributing to mitochondrial dysfunction and loss of cellular repair capacity. They also demonstrated how raising NAD+ re-activates **sirtuins**, silences inflammatory genes, and improves DNA stability.

_“NAD+ is the closest we’ve gotten to a fountain of youth. When levels go up, cells think they’re young again.” — **David Sinclair**_

Most of Sinclair’s focus has been on **NMN** and **NR**, compounds attractive partly because they are patentable. Yet the biology is the same: whether the source is **niacin**, **niacinamide**, or a newer molecule, the goal is restoration of **NAD+**. 

**Niacin** remains the most affordable and effective precursor — it was simply discovered too early to fit the commercial model.

### Cardiovascular Power

**Niacin** is one of the most powerful agents for improving **cholesterol balance**. Decades of clinical use showed that it can dramatically **raise HDL cholesterol**, **lower triglycerides**, and reduce the presence of small, dense **LDL** particles that are most associated with heart disease. 

While older trials demonstrated impressive improvements in HDL and triglycerides, later large-scale studies using sustained-release forms combined with statins (e.g., _AIM-HIGH_, _HPS2-THRIVE_) failed to improve outcomes. These used formulations and combinations that differ from Hoffer’s approach, highlighting how form and context determine results.

The characteristic **“flush”** from niacin is not a side effect but a **physiological signal** — a prostaglandin-mediated dilation of capillaries that improves blood flow and microcirculation.

Pharmaceutical companies later tried to create **“no-flush”** and **sustained-release** forms of niacin, but none matched the broad lipid and vascular benefits of simple **nicotinic acid**. In fact, these altered forms were often less effective and sometimes more stressful to the liver — leading Hoffer to insist that only **immediate-release niacin** should be used.  

_“If it doesn’t flush, it doesn’t work.” — **Abram Hoffer**_

To understand why these altered forms failed — and why they harmed niacin’s reputation — we need to look at the **sustained-release problem** more closely.

### The Sustained-Release Problem

Much of niacin’s modern “bad reputation” comes not from Hoffer’s **immediate-release niacin**, but from **sustained-release (SR) or extended-release (ER) forms** introduced to minimize the **flush**. These forms altered the way the liver metabolized niacin, leading to problems not seen with plain **nicotinic acid**.

**Effectiveness**  
- **IHN (inositol hexanicotinate)**, marketed as “no-flush niacin,” does not liberate free nicotinic acid in meaningful amounts.  
- It fails to **raise HDL**, **lower triglycerides**, or provide the **psychiatric and vascular benefits** of niacin.  
- Clinical studies confirm it simply does not work the same way as **immediate-release niacin**.  

**Documented toxicity**  
- **SR/ER niacin** is metabolized differently, saturating clearance pathways.  
- Trials reported **elevated liver enzymes, jaundice, and, in rare cases, serious liver injury** — risks not seen with immediate-release niacin.  

Reports of **hepatitis** and, rarely, **acute liver failure** were **disproportionately linked to SR/ER niacin**, not the immediate-release form Hoffer used.

**Hoffer’s Position**  
- Hoffer consistently warned against **“no-flush” niacin**.  
- For him, the **flush** was not only harmless but therapeutic — proof the compound was active.  
- He explicitly rejected **no-flush derivatives** as both ineffective and potentially harmful.  

Pharmaceutical companies often used these compromised forms in large studies. When problems emerged, the blame fell on **niacin in general**, creating the illusion that it was unsafe — when in fact, **immediate-release niacin has a long record of safety and effectiveness**.

### Detox and Liver Function

Another unique property of **niacin** is its ability to **mobilize fatty acids from adipose tissue**. This has been used in **detoxification protocols** combining niacin with sauna therapy to support the mobilization of fat-soluble toxins like **PCBs, dioxins, and pesticides**. While the evidence base for toxin clearance remains debated, niacin’s role in lipid mobilization and hepatic metabolism is well established.

Controlled studies on detoxification are limited, yet mechanistic data show niacin’s activation of lipolysis and improvement in liver enzyme profiles, particularly when combined with antioxidants and hydration.

In fatty-liver contexts, pharmacologic **immediate-release niacin** has shown signals of reducing hepatic fat and lowering **elevated ALT/AST** in small trials and mechanistic studies. When paired with antioxidants such as **vitamin C** or **glutathione**, its **detoxifying effect** may be amplified. **Form and dose matter:** **SR/ER products** and very high doses increase hepatotoxic risk; monitoring is prudent at gram-level intakes.

These **detox effects** are distinct from **niacinamide**, its flush-free cousin, which acts differently in the body.

### Niacin vs. Niacinamide

Although they share the same molecular backbone, **niacin** and **niacinamide** act differently in the body. **Niacin (nicotinic acid)** produces the **flush**, improves cholesterol, mobilizes fat, and exerts many of the **psychiatric and circulatory effects** Hoffer observed. 

**Niacinamide (nicotinamide)**, on the other hand, does not cause flushing and still raises **NAD+**, but it does not improve cholesterol or fat detoxification. 
It does, however, have strong **anti-inflammatory effects** and has been particularly useful in **arthritis, skin conditions, and some forms of neuroinflammation**.
Case reports describe hepatotoxicity mainly at 3–9 g/day, typically with sustained intake or pre-existing liver strain; doses ≤1.5 g/day are generally regarded as safe.

**Both are valuable — but they are not interchangeable.**

### Tryptophan, Serotonin, and Mood

The body can synthesize **niacin** from **tryptophan**, but the conversion is so inefficient that it becomes clinically relevant. 

When **tryptophan** is diverted into the niacin pathway, less is available for **serotonin** production. This explains why **niacin deficiency** can contribute not only to pellagra but also to **mood disturbances, insomnia, and anxiety**. 

Supplementing **niacin** therefore protects tryptophan and preserves **serotonin balance** — another reason why Hoffer observed psychiatric improvements.

> **Takeaway:**  
> **Serotonin** is a neurotransmitter central to mood, sleep, appetite, and overall well-being. Preserving tryptophan for serotonin synthesis helps stabilize mood and sleep — part of why **niacin repletion** can feel restorative.

### Immune and Inflammation

During **infections**, immune cells consume large amounts of **NAD+** as they fuel defense mechanisms. **Niacin** and **niacinamide** help restore balance through several mechanisms:

**Improved macrophage activity:** Enhances the ability of immune cells to engulf and destroy pathogens.  
_**Niacin** supplies NAD+ for energy and redox reactions, powering phagocytosis, the oxidative burst, and balanced immune signaling._  

**Reduced cytokine storms:** Lowers excessive inflammatory signaling that can damage tissues.  
_Through the **GPR109A (HCAR2) receptor** and **sirtuin activation**, niacin helps calm overproduction of pro-inflammatory cytokines like **TNF-α** and **IL-6**._  

**DNA repair support:** Provides **NAD+** for enzymes that maintain genome stability under stress.  
_**PARP enzymes** require NAD+ to repair DNA damage during infection and inflammation; niacin keeps this pathway active._  

**Autoimmune modulation:** **Niacinamide** calms overactive immune pathways, reducing inflammation in arthritis and similar conditions.  
_By inhibiting **NF-κB** and supporting regulatory T-cells, niacinamide helps prevent immune attacks on the body’s own tissues._  

Together, these effects highlight **niacin’s role** not only in **energy production** but also in strengthening and regulating **immune defenses**.

### The Flush: Therapy in Disguise

The **niacin flush** — warmth, redness, tingling — is often the reason people abandon therapy. Yet this **flush** itself may be **therapeutic**. 

It results from **prostaglandin-mediated dilation of small blood vessels**, improving microcirculation and capillary repair in tissues that often suffer from poor flow, such as the skin, brain, and extremities. 

The **flush** diminishes with continued use as tolerance develops, but its benefits likely extend beyond the sensation it produces.

### Cofactor Protocol — Supporting Niacin’s Work

**Niacin** works best when accompanied by a well-structured **cofactor protocol**. These cofactors are not mere “extras” but essential components that Dr. **Abram Hoffer** incorporated into his original protocol to ensure both tolerance and effectiveness. 

Proper **nutrient support** helps prevent side effects, supports metabolic pathways, and enhances niacin’s therapeutic benefits.

**Core Cofactors** (_Essential_, _Always Paired_)  
- **Vitamin C:** Prevents the formation of **adrenochrome**, reduces oxidative stress, lowers uric acid, and supports methylation. It is fundamental to niacin’s psychiatric and detox effects.  
- **Vitamin B12 and Folate:** Replenish **methyl donors**, maintain healthy homocysteine levels, and support methylation pathways critical to niacin metabolism and overall cellular function.  
- **Glycine:** Supports hepatic clearance pathways and detoxification. Supplementing 2–3 grams per day can assist liver function, with magnesium glycinate offering a dual source of glycine and magnesium.  

**Secondary Supports (Helpful Additions)**  
- **Magnesium:** Supports enzymatic reactions, improves insulin sensitivity, and helps reduce niacin-induced flushing.  
- **Antioxidants (NAC, Milk Thistle, Glutathione):** Protect the liver, enhance detoxification, and reduce oxidative stress associated with high-dose niacin therapy.  
- **Tart Cherry and Quercetin:** Help balance uric acid levels, reducing the risk of gout and supporting kidney function during niacin use.  

**Optional/Targeted Supports (Case-Specific)**  
- **Chromium:** May support insulin sensitivity in individuals experiencing glucose metabolism changes.  
- **Additional Liver Supports:** Depending on individual liver health, supplements such as silymarin or alpha-lipoic acid can be considered to further enhance detox pathways.  
- **Electrolytes and Hydration:** Important during detoxification protocols involving sauna or extended niacin use to maintain balance and support elimination.  

Integrating these **cofactors** into **niacin therapy** is crucial for optimizing outcomes across the various protocols outlined below. Whether the goal is **psychiatric support, cardiovascular health, detoxification, or general maintenance**, these nutrients form the foundation that allows niacin to work safely and effectively.  

As Hoffer himself reminded, healing is not mysterious chemistry but simply giving the body what it needs in the right amounts:  

_“Mental illness is usually biochemical illness. Schizophrenia is vitamin B-3 (niacin) dependency. [But] patients are given drugs and released. The new mental hospital today is the streets.” — **Abram Hoffer**_

### Protocols and Dosage  

The use of **niacin** depends on the goal.  

**General health / maintenance**  
- **Niacin (flush):** 50–200 mg daily, or alternatively 100–500 mg 2–3 times per week for vascular benefits while avoiding tolerance  
- **Niacinamide:** 250–500 mg per day  
- Supports **NAD+**, circulation, and baseline metabolic health without major side effects.  

**Psychiatric / orthomolecular (Hoffer’s protocol)**  
- **Niacin (flush):** 1,000 mg three times daily (3 g total, sometimes higher)  
- **Vitamin C:** 3–6 g per day alongside  
- Used for **schizophrenia, depression, and alcoholism** with significant clinical success.  

**Cardiovascular / lipid management**  
- **Niacin (flush):** 2–4 g per day in divided doses  
- Most effective natural method to **raise HDL, lower triglycerides, and improve cholesterol profile**.  

**Detoxification protocols**  
- **Niacin (flush):** 500 mg up to 2 g per session  
- Combined with **sauna, antioxidants, electrolytes, and hydration** to mobilize lipid-stored toxins  
- Not usually taken daily long-term, but in cycles for cleansing.  

_See **Cofactor Protocol** section above for details on essential nutrient supports._

**Cycling** is also valuable. Because tolerance to the flush develops over time, periodic breaks — for example, two to three months on followed by one month off — may restore responsiveness. 

_**Monitoring tip:** For gram-level use, check liver enzymes (ALT/AST) at baseline and again after 6–8 weeks (earlier if symptoms arise)._

Another strategy is to combine daily **niacinamide** with periodic **flush niacin** a few times per week, providing steady **NAD+** support while still gaining the vascular and detox benefits of the flush.

### Risks and Bottlenecks

At gram-level doses, **niacin** reveals certain **metabolic bottlenecks**. 

- **Liver safety:** Immediate-release niacin above ~500 mg/day can cause **transient, asymptomatic ALT/AST elevations**; serious injury is uncommon. Risk increases at gram doses and is disproportionately associated with **sustained/extended-release products** or with switching from immediate- to sustained-release forms. **Nicotinamide** is generally well tolerated up to ~1–1.5 g/day, but **hepatotoxicity has been reported at ≥3 g/day** (and occasionally at lower doses in specific populations). Prefer **immediate-release niacin** and **monitor liver enzymes** during high-dose therapy.  
  Routine monitoring of liver enzymes (ALT/AST) is recommended when using doses above 1.5 g/day for longer than 6–8 weeks.
  Transient, mild enzyme elevations can occur early in therapy and usually resolve spontaneously, but persistent elevations warrant dose adjustment or discontinuation.
- **Uric acid:** Niacin and its metabolites compete with uric acid for renal excretion, raising the risk of **gout**.
- **Glucose/insulin:** By altering fat metabolism, high doses can modestly reduce insulin sensitivity; this is usually mild and reversible.

These effects underscore why **cofactors** are important in any sustained high-dose use.

### Legacy and Modern Carriers of the Torch

**Linus Pauling** supported Hoffer’s work and coined the term _orthomolecular medicine_. **Andrew Saul** has continued publishing case reports and clinical evidence under the **Orthomolecular Medicine News Service**. Modern **NAD+** researchers such as **Sinclair** and **Brenner** indirectly validate niacin’s role, even if attention is directed toward newer, patentable molecules.

_“Dr. Hoffer’s work was fifty years ahead of its time. Psychiatry ignored him, but his patients never did.” — **Andrew Saul**_

_“It takes approximately forty years for innovative thought to be incorporated into mainstream thought. I expect and hope that orthomolecular medicine, within the next five to ten years, will cease to be a specialty in medicine and that all physicians will be using nutrition as an essential tool in treating disease.” — **Abram Hoffer**_

### Closing Reflection

**TL;DR — Niacin in Three Lines**

- **Upstream NAD+:** Immediate‑release **niacin (nicotinic acid)** safely raises **NAD+** with built‑in rate‑limiting; pair with **vitamin C** and **methylation cofactors**.
- **Targets:** Psychiatry (**Hoffer**), cardiovascular lipids (**↑HDL, ↓TG**), detox/sauna (**mobilizes adipose toxins**), immune balance; **flush** is a therapeutic vasodilatory signal.
- **Form matters:** Prefer **immediate‑release**; avoid **sustained/extended‑release** and most **“no‑flush” products** due to reduced benefits and higher liver‑risk; monitor labs at gram‑level use.

Some of Hoffer’s patients described recovery not just as a reduction in hallucinations, but as a profound _return of clarity_, as if a veil had lifted from their minds. **Niacin’s role goes beyond neutralizing a toxin; it restores the integrity of the brain’s signal, stabilizing its chemistry and renewing its flow of energy. As NAD+ levels rise, the brain’s capacity for steady function is restored with renewed clarity and resilience.**

**Niacin is more than a vitamin. It serves as a methyl acceptor that stabilizes brain chemistry, a precursor to NAD+ that fuels mitochondrial energy production and DNA repair, a vascular dilator that enhances circulation, a detox activator that mobilizes lipid-stored toxins, and a psychiatric ally supporting recovery in many cases of schizophrenia and addiction.** 

What began as Hoffer’s search for a psychiatric tool may, in retrospect, be one of the most powerful _metabolic correctors_ of the 20th century — still overlooked, still underestimated.

As the world rediscovers **NAD+** in the language of longevity science, Hoffer’s simple insight — that **niacin can restore balance** — may prove more timely than ever.

_“When you give the body what it is missing, the symptoms vanish, not because they are suppressed, but because they no longer need to exist.” — **Abram Hoffer**_

---

### Selected References & Further Reading

- Hoffer A, Saul AW, Foster HD. *Niacin: The Real Story.* 2nd ed. Basic Health; 2023.
- Pauling L. "Orthomolecular Psychiatry." *Science.* 1968;160(3825):265–271.
- Preiss J, Handler P. "Biosynthesis of diphosphopyridine nucleotide." *J Biol Chem.* 1958;233:488–492. (Preiss–Handler pathway)
- Goldberger J. *The Conquest of Pellagra.* US Public Health Service reports, 1914–1929.
- Wilson W (Bill W.). Letters and memos on niacin and recovery (archival accounts referenced in Hoffer & Saul).
- Sinclair DA. *Lifespan: Why We Age—and Why We Don’t Have To.* Atria; 2019. (NAD+ and sirtuins overview)
- Orthomolecular Medicine News Service (OMNS). Selected case reports and reviews on niacin therapy.
- Dermatology: Chen AC et al. "A Phase 3 RCT of nicotinamide for skin-cancer chemoprevention." *NEJM.* 2015;373:1618–1626. (500 mg BID safety/tolerability)
- Hepatology/NAFLD: Reviews and small trials on niacin in fatty liver and lipid metabolism (see Hoffer/Saul; recent hepatology reviews).

---

### Revision Log

**2025-10-13**
- Added clarifying note on adrenochrome hypothesis (historical vs. modern evidence).
- Refined NAD+ pathway explanation for balance between niacin and NMN/NR.
- Expanded detox section with clarification on evidence base and hepatic mechanisms.
- Updated liver-safety notes to describe transient enzyme elevations.
- Added this revision log for transparency and version tracking.
